Calliditas Therapeutics AB (publ) (CALT) NASDAQ

40.00

-0.0399(-0.10%)

Updated at September 20, 2024 04:00PM

Currency In USD

Valuation

Market Cap6.96B
Enterprise Value6.96B
P/E Ratio-38.03
PEG Ratio-4.48
Price/Sales Ratio13.14
Price/Book Ratio104.57
Enterprise/Revenue13.39
Enterprise/EBITDA-48.66

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-0.34
Operating Margin-0.28

Management Effectiveness

Return On Assets-0.17
Return On Equity-2.59

Income Statement

Revenue1.21B
Revenue/Share15.93
Gross Profit1.13B
EBITDA-367.8M
Net Income-466.19M
Diluted EPS-17.38

Balance Sheet

Total Cash797.28M
Total Cash/Share14.85
Total Debt1.01B
Total Debt/Equity9.44
Current Ratio2.69
Book Value Per Share1.99

Price History

52-Week Change129.16
52-Week High43
52-Week Low15.25
Moving Average 50 Days39.65
Moving Average 200 Days29.6

Statistics

Average Volume7,730
Shares Outstanding53.69M
% Held by Institutions0.03

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A